The unfolded protein response (UPR) is a cellular homeostatic circuit regulating protein 2 synthesis and processing in the ER by three ER-to-nucleus signaling pathways. One 3 pathway is triggered by the inositol-requiring enzyme 1 (IRE1), which splices the X-box 4 binding protein 1 (XBP1) mRNA, thereby enabling expression of XBP1s. Another UPR 5 pathway activates the activating transcription factor 6 (ATF6). Here we show that murine 6 cytomegalovirus (MCMV), a prototypic β-herpesvirus, harnesses the UPR to regulate its own 7 life cycle. MCMV activates the IRE1-XBP1 pathway early post infection to relieve repression 8 by XBP1u, the product of the unspliced XBP1 mRNA. XBP1u inhibits viral gene expression 9 and replication by blocking the activation of the viral major immediate-early promoter by 10 XBP1s and ATF6. These findings reveal a redundant function of XBP1s and ATF6 as 11 activators of the viral life cycle, and an unexpected role of XBP1u as a potent repressor of 12 both XBP1s and ATF6-mediated activation. 13 14 Key words: unfolded protein response / transcription factor / XBP1u / ATF6 / 15 cytomegalovirus. 16 17 18
Introduction 19
The endoplasmic reticulum (ER) is responsible for synthesis, posttranslational modification, 20 and folding of a substantial portion of cellular proteins. When protein synthesis is increased 21 or ER function is compromised, the folding capacity of the ER may get out of balance, 22 leading to an accumulation of unfolded or misfolded proteins in the ER. To alleviate ER 23 stress and restore homeostasis, the cell activates three ER-to-nucleus signaling pathways, 24 collectively called the unfolded protein response (UPR), which lead to a reduced protein 25 synthesis and an increased expression of folding chaperones and ER-associated 26 degradation (ERAD) factors (Walter & Ron, 2011) . Subsequently, ER folding capacity 27 increases and terminally misfolded protein species are exported from the ER and targeted for 28 proteasomal degradation (Christianson & Ye, 2014) . 29
In mammalian cells, the UPR comprises three main signaling pathways named after 30 the initiating ER stress sensors: PERK (PKR-like ER kinase), ATF6 (activating transcription 31 factor 6), and IRE1 (inositol-requiring enzyme 1) (Walter & Ron, 2011) . Upon activation by 32 ER stress, PERK phosphorylates the translation initiation factor eIF2α, which leads to a 33 massive attenuation of protein synthesis and an immediate reduction of the protein load in 34 the secretory system. However, phosphorylated eIF2α selectively supports the translation of 35 selected cellular proteins such as the transcription factor ATF4, which activates a negative 36 feedback loop resulting in dephosphorylation of eIF2α (Novoa et al, 2001) . 37 and expression of transcription factor XBP1s, comprising an N-terminal basic leucine zipper 48 (bZIP) domain followed by a C-terminal transcription activation domain. In contrast, the 49 unspliced XBP1 mRNA encodes XBP1u, which lacks the transcription activation domain but 50 contains a hydrophobic patch in the C-terminal part. XBP1u is rapidly degraded and has a 51 short half-life (Tirosh et al, 2006) . It can interact with XBP1s and ATF6(N) and target them for 52 proteasomal degradation. Therefore, XBP1u is thought acts as a negative regulator involved 53 Moreover, XBP1u affects autophagy by interacting with transcription factor FOXO1 (Zhao et 55 al, 2013) . Apart from mediating XBP1 mRNA splicing, IRE1 can also cleave ER-associated 56 mRNA molecules that contain a specific recognition motif (Moore & Hollien, 2015). This 57 process, which leads to mRNA degradation, is called regulated IRE1-dependent mRNA 58 decay (RIDD). However, the importance of RIDD in different cellular processes such as lipid 59 metabolism, antigen presentation, and apoptosis remains incompletely understood (Maurel 60 et al, 2014) . 61
During viral replication large quantities of viral proteins must be synthesized. Folding, 62 maturation, and posttranslational modification of secreted and transmembrane proteins take 63 place in the ER and require a plethora of chaperones, foldases, and glycosylating enzymes. 64
While properly folded proteins are transported to the Golgi, unfolded or misfolded proteins 65 are retained in the ER and exported to the cytosol for proteasomal degradation via the ER-66 associated protein degradation (ERAD) pathway (Smith et al, 2011). However, the high 67 levels of viral envelope glycoproteins that are being synthesized particularly during the late 68 phase of the viral life cycle can overwhelm the folding and processing capacity of the ER and 69 cause accumulation of unfolded and misfolded proteins in the ER (Zhang & Wang, 2012) . the CMVs have acquired the ability to moderate immune recognition and modulate cellular 75 stress responses to their own benefit (Alwine, 2008; Mocarski, 2002) . Considering the 76 important role of the UPR in controlling cell fitness, it is hardly surprising that the CMVs have 77 evolved means to modify the UPR. For instance, human and murine CMV (HCMV and 78 MCMV) induce PERK activation, but limit eIF2α phosphorylation. By doing this the CMVs 79 induce lipogenesis by activating the cleavage of sterol regulatory element binding protein 1 84 (Yu et al, 2013) . We have previously shown that both, MCMV and HCMV, downregulate 85 IRE1 levels and inhibit IRE1 signaling at late times post infection. This downregulation is 86 mediated by the viral proteins M50 and UL50, respectively (Stahl et al, 2013) . However, a 87 real-time transcriptional profiling study has revealed that cellular ER stress response 88 transcripts are upregulated as early 5-6 hours after MCMV infection (Marcinowski et al, 89
2012). 90
Here we show that MCMV transiently activates the IRE1-XBP1 pathway at early times 91 postinfection in order to relieve repression of viral gene expression and replication by XBP1u. 92
When IRE1-mediated XBP1 mRNA splicing is inhibited, XBP1u blocks the activation of the 93 viral major immediate-early promoter (MIEP) by XBP1s and ATF6(N). Thus, MCMV exploits 94 UPR signaling to boost the activity of its most important promoter. Moreover, these findings 95 reveal a redundant function of XBP1s and ATF6 as activators of viral gene expression and 96 replication, and an unexpected role of XBP1u as a potent repressor of both XBP1s and 97 ATF6-mediated activation. 98 attachment and entry into cells but required viral gene expression. MCMV-induced XBP1 112 splicing was also suppressed by cycloheximide (CHX, a translation inhibitor), but not by 113 phosphonoacetic acid (PAA), an inhibitor of viral DNA replication and late gene expression 114 ( Fig. 1B) . These results suggested that the transient activation of the IRE1-XBP1 pathway is 115 caused by viral proteins expressed at immediate-early or early times post infection. 116
To determine whether IRE1 signaling is important for the MCMV life cycle, we used 117 Ire1 -/cells expressing IRE1-GFP under tight control of a tetracycline-inducible promoter ( Fig.  118 2A) for analyses of viral replication. IRE1-GFP expression was induced with different 119 concentrations of doxycycline, and cells were infected at low or high multiplicity of infection 120 (MOI) for multi-step and single-step growth curves, respectively ( Fig. 2B and C). In both 121 types of replication analysis, MCMV replicated to low titers when IRE1 expression was 122 induced with very low or very high doxycycline concentrations. High MCMV titers (~10 6 123 infectious units per ml), comparable to those obtained in wildtype (WT) MEFs, were attained 124 only upon moderate induction of IRE1-GFP with 5 to 10 nM doxycycline ( Fig. 2B MEFs. For each gene knockout, two independent cell clones were generated with different 135 guide RNAs. The absence of the respective gene products was verified by immunoblot 136 analysis ( Fig. 3A ). Then the cell clones were used to assess MCMV replication. In Ire1 ko 137
MEFs, viral replication was reduced by two orders of magnitude as compared to WT MEFs 138 ( Fig. 3B ), similar to the reduction seen in IRE1-GFP cells without doxycycline induction ( Fig.  139 2B). By contrast, MCMV replication was virtually unimpaired in the absence of Xbp1 (Fig. 3B ) 140
or Traf2 (Fig. 3C ). We also analyzed the expression of a viral immediate-early (IE1), an early 141 (M57), and a late protein (gB) at different times post infection. Compared to WT MEFs, the 142 expression of all three proteins was reduced in Ire1 ko MEFs ( Fig. 3D ), but not in Xbp1 or 143
Traf2 ko MEFs ( Fig. 3E and F ). 144
Next we tested whether the RNAse activity of IRE1 is required for efficient MCMV 145 replication. To do this, WT IRE1 or an "RNAse-dead" IRE1 K907A mutant (Tirasophon et al, 146
2000) was expressed in Ire1 ko MEFs by retroviral transduction. Expression of WT and 147 mutant IRE1 and the ability to splice Xbp1 was verified by immunoblot analysis (Fig. 4A ).
While expression of WT IRE1 restored MCMV replication to high titers, expression of IRE1 149
K907A did not increase MCMV titers ( Fig. 4B ), indicating that the IRE1 RNase activity is 150 necessary for efficient MCMV replication. 151 152 XBP1u inhibits MCMV replication. 153
Our observations that the RNase activity of IRE1 is required for efficient MCMV replication, 154 but XBP1 is not, allowed two possible explanations: (i) MCMV replication could benefit from 155 RIDD, another RNase-dependent function of IRE1. However, this possibility is difficult to 156 verify as selective inactivation of RIDD is complicated. (ii) Alternatively, MCMV replication 157 could be inhibited by XBP1u, the product of the unspliced Xbp1 mRNA, since Ire1 ko cells 158 differ from other cells in that they express only XBP1u (Fig. 3A) . To test the latter option, we 159 used two experimental approaches. First, we knocked out Ire1 in Xbp1-deficient cells ( interact with ATF6 and inhibit its activity (Yoshida et al, 2009 ). Therefore, we tested whether 183 the loss of both, XBP1 and ATF6, was detrimental for MCMV replication. First, we analyzed impaired ( Fig. 6A and B ). When we knocked out Xbp1 in Atf6 -/cells by CRISPR/Cas9 gene 186 editing ( Fig. 6C ), MCMV replication was substantially reduced in Atf6/Xbp1 dko cells ( Fig To analyze the function of these putative transcription factor binding 199 sites, we inserted the WT MIEP and six mutant versions (Table S1) Again, the MIEP activities were consistent with the results of the viral replication kinetics 208 (Figs. 5B and 6D). Thus, we concluded that activation of the MCMV MIEP correlated with 209 viral replication in the same cells. We also found that the activity of the MIEP had a 210 substantially reduced activity when all 5 ACGT motifs were mutated ( Fig. 7B-D ). 211
Next we tested whether XBP1s and ATF6(N), the active form of ATF6, can activate 212 the MCMV MIEP and whether XBP1u can repress it. To assess the contribution of 213 endogenous levels of the TFs, Xbp1 ko, Atf6 ko, and Xbp1/Atf6 dko cells were used. In Xbp1 214 ko cells, MIEP activity was slightly increased by expression of XBP1s, but substantially 215 reduced by XBP1u. XBP1u also antagonized XBP1s in a dose-dependent manner ( Fig. 7E) . 216
A similar result was obtained in Atf6 -/cells: MIEP activity was slightly increased by 217 expression of ATF6(N), but substantially reduced by XBP1u. XBP1u also antagonized 218 ATF6(N) in a dose-dependent manner (Fig. 7F ). In Atf6/Xbp1 dko cell, expression of either 219 XBP1s or ATF6(N) was sufficient to increase MIEP activity substantially. XBP1u alone did 220 not reduce MIEP activity in these cells, but it antagonized the activity of ATF6(N) expressed 221 by transfection ( Fig. 7G ). Taken together, these results suggest that both, XBP1s and 222 ATF6(N), can activate the MCMV MIEP in a largely redundant fashion, and that XBP1u 223 represses the activity of both, XBP1s and ATF6(N). 224 225
Motif 4 is necessary and sufficient for MIEP activation by XBP1s and ATF6(N). 226
As a first step to determine, which of the five ACGT motifs function as XBP1s and/or 227 ATF6(N) binding sites for promoter activation, we measured the binding of these TFs to 228 TFs lacking the DNA-binding domain (ΔDBD) served as negative controls. In this DPI-ELISA, 236
XBP1s and XBP1u showed the strongest interaction with motifs 3 and 4, whereas ATF6(N) 237
interacted with motifs 2 and 4 ( Fig. 8B) . 238
Next we used the luciferase reporter assay to test which of the five motifs was 239 required for MIEP activation by XBP1s and ATF6(N). We used five mutant MIEPs having one 240 of the ACGT motifs changed to CTAG. These reporter plasmids were transfected into 241
Atf6/Xbp1 dko cells, together with expression plasmids for XBP1s, XBP1u, and ATF6(N). As We tested then whether motif 4 was also sufficient for MIEP activation by XBP1s and 246 ATF6(N). Motif 4 was restored in MIEP-all-mut to generate a MIEP containing only ACGT 247 motif 4 (MIEP-4-only, Table S1 ). Indeed, MIEP-4-only was inducible by XBP1s and ATF6(N) 248 ( Fig. 9B ), suggesting that motif 4 is sufficient to confer MIEP responsiveness to XBP1s and 249 ATF6. To determine whether motif 4 is also of crucial importance for MCMV replication, we 250 in a massively (~100-fold) reduced production of progeny virus (Figs. 2, 3B, and 5D ). In IRE1 298 ko cells, the XBP1 transcript is expressed from its endogenous promoter, not from a strong 299 heterologous promoter. Thus, the observed effects cannot be dismissed as overexpression 300 artifacts. Moreover, the fact that MCMV replication is massively reduced in IRE1 ko cells 301 ( Figs. 2 and 3B ), but not in Ire1/Xbp1 dko cells (Fig. 5B) , demonstrates that XBP1u 302 expression rather than the absence RIDD is responsible for the observed effect. Hence, the 303 data of our study suggest that XBP1u plays an unexpectedly important role as a repressor, at Guide RNAs (Table S2) 
Replication kinetics 414
Cells were seeded in 6-well plates and infected by an MOI of 3 or 0.1 for single or multi-step 415 replication kinetics, respectively. Six hpi the medium was exchanged to remove the 416 inoculum. Supernatant samples were harvested at different times post infection, and viral 417 titers were determined on 10.1 fibroblasts using the TCID 50 method. 418
419

MIE promotor activity assay 420
The firefly luciferase reporter vector pGL3-Basic, the renilla luciferase control vector 421 pGL4.73, and the Dual-Glo Luciferase assay system were purchased from Promega. WT 422 and mutant versions of the MCMV MIE promotor (Table S1) 
